A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab

Berger, MD; Stintzing, S; Heinemann, V; Cao, S; Yang, DY; Sunakawa, Y; Matsusaka, S; Ning, Y; Okazaki, S; Miyamoto, Y; Suenaga, M; Schirripa, M; Hanna, DL; Soni, S; Puccini, A; Zhang, W; Cremolini, C; Falcone, A; Loupakis, F; Lenz, HJ

Lenz, HJ (reprint author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, 1441 Eastlake Ave, Los Angeles, CA 90033 USA.

CLINICAL CANCER RESEARCH, 2018; 24 (4): 784

Abstract

Purpose: Vitamin D exerts its inhibitory influence on colon cancer growth by inhibiting Wnt signaling and angiogenesis. We hypothesized that SNPs in g......

Full Text Link